Lung Cancer Market 2028 By Diagnostic, Therapeutic | The Insight Partners

report image

Lung Cancer Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Diagnostic (Test, Technology); Therapeutic (Disease Type, Molecule Type)

Report Code: TIPRE00003018 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming


Lung Cancer is an uncontrolled unwanted growth of cells abnormally in one or both lungs of an individual, which decreases the ability of lungs to provide oxygen into the blood stream increasing the tumor or cell growth. This is largely seen in individuals prone to smoking habits and may result into death if untreated on time.


The Lung Cancer market is anticipated to grow in the forecast, owing to the factors such as growing prevalence of cancer, rising population who smoke, introduction of novel and innovative products and market players getting involved in introduction of therapies and drugs.


The "Global Lung Cancer Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Lung Cancer market with detailed market segmentation by diagnostic, therapeutic and geography. The global Lung Cancer market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Lung Cancer market players and offers key trends and opportunities in the market.


The global Lung Cancer market is segmented on the basis of diagnostic and therapeutic. Based on diagnostic the market is segmented into tests, technologies. Based therapeutic disease type, molecule type.

Get more information on this report :


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Lung Cancer market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Lung Cancer market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Lung Cancer market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Lung Cancer market in these regions.

Get more information on this report :


The reports cover key developments in the Lung Cancer market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Lung Cancer market are anticipated to lucrative growth opportunities in the future with the rising demand for Lung Cancer market in the global market. Below mentioned is the list of few companies engaged in the Lung Cancer market.

The report also includes the profiles of Lung Cancer market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Quest Diagnostics
  •  AstraZeneca
  •  GlaxoSmithKline
  •  Agennix
  •  Eli Lilly
  •  Boston Biomedical
  •  F. Hoffmann-La Roche Ltd
  •  Siemens Healthcare GmbH
  •  Oncimmune Holdings Plc
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Get more information on this report :

The List of Companies

- Quest Diagnostics
- AstraZeneca
- GlaxoSmithKline
- Agennix
- Eli Lilly
- Boston Biomedical
- F. Hoffmann-La Roche Ltd
- Siemens Healthcare GmbH
- Oncimmune Holdings Plc

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount